| Pharmaceutical active ingredients: |
| Anisotropine Methylbromide |
| Available forms, composition and doses of Octatropine: |
| N / A |
| Octatropine medical category: |
| Human:AnticholinergicsParasympatholytics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Eubispasme Codethyline Suppositories | Anisohydrocinnamol Oleate; Ethylmorphine Camphorate; Opium | Chiesi |
| Elgucare-S | Anisomeles Indica Herba; Astragalus Membranaceus Radix; Boussingaultia Gracilis; Glycyrrhiza Glabra Radix; Paederia Scandens Radix; Polygonatum Odoratum Rhizome; Salvia Miltiorrhiza Radix | Y.S.P. Industries |
| Anisotropine | Anisotropine Methylbromide | Watson Pharmaceuticals |
| Endovalpin | Anisotropine Methylbromide | Unidentified Pharmaceutical Company |
| Lytispasm | Anisotropine Methylbromide | Unidentified Pharmaceutical Company |
| Valpin | Anisotropine Methylbromide | Bristol-Myers Squibb |
| Eminase | Anistreplase | GlaxoSmithKline; Carinopharm; Medison Pharma; Shire; Torrex Pharma; Tramedico; WellSpring Pharmaceuticals |
| Fibrit | Anistreplase | Neo-Farmaceutica |
| Iminase | Anistreplase | Madaus |
| Multilase | Anistreplase | Sigma-Tau Pharmaceuticals |